nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylphenobarbital—Fosphenytoin—epilepsy syndrome	0.0954	0.292	CrCtD
Methylphenobarbital—Primidone—epilepsy syndrome	0.0954	0.292	CrCtD
Methylphenobarbital—Phenobarbital—epilepsy syndrome	0.0703	0.215	CrCtD
Methylphenobarbital—Phenytoin—epilepsy syndrome	0.0654	0.2	CrCtD
Methylphenobarbital—GRIA2—epilepsy syndrome	0.0407	0.224	CbGaD
Methylphenobarbital—CHRNA7—epilepsy syndrome	0.0288	0.159	CbGaD
Methylphenobarbital—GABRA5—epilepsy syndrome	0.0274	0.151	CbGaD
Methylphenobarbital—GRIK2—epilepsy syndrome	0.0269	0.148	CbGaD
Methylphenobarbital—GABRA1—epilepsy syndrome	0.0235	0.13	CbGaD
Methylphenobarbital—CHRNA4—epilepsy syndrome	0.023	0.127	CbGaD
Methylphenobarbital—Glutethimide—Primidone—epilepsy syndrome	0.0133	0.0666	CrCrCtD
Methylphenobarbital—Ethotoin—Primidone—epilepsy syndrome	0.0123	0.0612	CrCrCtD
Methylphenobarbital—Primidone—Phenobarbital—epilepsy syndrome	0.012	0.06	CrCrCtD
Methylphenobarbital—Antipyrine—Clobazam—epilepsy syndrome	0.0119	0.0596	CrCrCtD
Methylphenobarbital—Primidone—Phenytoin—epilepsy syndrome	0.0112	0.0558	CrCrCtD
Methylphenobarbital—Fosphenytoin—Phenytoin—epilepsy syndrome	0.0112	0.0558	CrCrCtD
Methylphenobarbital—CYP2C19—epilepsy syndrome	0.0111	0.0609	CbGaD
Methylphenobarbital—Methsuximide—Primidone—epilepsy syndrome	0.0106	0.0529	CrCrCtD
Methylphenobarbital—Phensuximide—Primidone—epilepsy syndrome	0.00993	0.0496	CrCrCtD
Methylphenobarbital—Glutethimide—Phenobarbital—epilepsy syndrome	0.00983	0.0491	CrCrCtD
Methylphenobarbital—Glutethimide—Phenytoin—epilepsy syndrome	0.00914	0.0456	CrCrCtD
Methylphenobarbital—GRIK2—Amobarbital—epilepsy syndrome	0.00907	0.0396	CbGbCtD
Methylphenobarbital—Ethotoin—Phenobarbital—epilepsy syndrome	0.00903	0.0451	CrCrCtD
Methylphenobarbital—Phenobarbital—Primidone—epilepsy syndrome	0.00886	0.0443	CrCrCtD
Methylphenobarbital—GRIA2—Amobarbital—epilepsy syndrome	0.00861	0.0376	CbGbCtD
Methylphenobarbital—Methsuximide—Phenobarbital—epilepsy syndrome	0.00781	0.039	CrCrCtD
Methylphenobarbital—Phenytoin—Primidone—epilepsy syndrome	0.00766	0.0383	CrCrCtD
Methylphenobarbital—Phenytoin—Fosphenytoin—epilepsy syndrome	0.00766	0.0383	CrCrCtD
Methylphenobarbital—GRIK2—Primidone—epilepsy syndrome	0.00754	0.033	CbGbCtD
Methylphenobarbital—CHRNA4—Amobarbital—epilepsy syndrome	0.0075	0.0328	CbGbCtD
Methylphenobarbital—CHRFAM7A—Amobarbital—epilepsy syndrome	0.0075	0.0328	CbGbCtD
Methylphenobarbital—CHRNA7—Amobarbital—epilepsy syndrome	0.0075	0.0328	CbGbCtD
Methylphenobarbital—Phenobarbital—Amobarbital—epilepsy syndrome	0.00739	0.0369	CrCrCtD
Methylphenobarbital—Methsuximide—Phenytoin—epilepsy syndrome	0.00726	0.0363	CrCrCtD
Methylphenobarbital—GRIA2—Primidone—epilepsy syndrome	0.00716	0.0313	CbGbCtD
Methylphenobarbital—GRIK2—Phenobarbital—epilepsy syndrome	0.00646	0.0282	CbGbCtD
Methylphenobarbital—CHRNA4—Primidone—epilepsy syndrome	0.00624	0.0273	CbGbCtD
Methylphenobarbital—CHRFAM7A—Primidone—epilepsy syndrome	0.00624	0.0273	CbGbCtD
Methylphenobarbital—CHRNA7—Primidone—epilepsy syndrome	0.00624	0.0273	CbGbCtD
Methylphenobarbital—GRIA2—Phenobarbital—epilepsy syndrome	0.00614	0.0268	CbGbCtD
Methylphenobarbital—Phenobarbital—Phenytoin—epilepsy syndrome	0.00607	0.0303	CrCrCtD
Methylphenobarbital—Methsuximide—Clobazam—epilepsy syndrome	0.00592	0.0296	CrCrCtD
Methylphenobarbital—Phenytoin—Phenobarbital—epilepsy syndrome	0.00565	0.0282	CrCrCtD
Methylphenobarbital—Phensuximide—Clobazam—epilepsy syndrome	0.00555	0.0277	CrCrCtD
Methylphenobarbital—CHRFAM7A—Phenobarbital—epilepsy syndrome	0.00535	0.0234	CbGbCtD
Methylphenobarbital—CHRNA4—Phenobarbital—epilepsy syndrome	0.00535	0.0234	CbGbCtD
Methylphenobarbital—CHRNA7—Phenobarbital—epilepsy syndrome	0.00535	0.0234	CbGbCtD
Methylphenobarbital—Phensuximide—Diazepam—epilepsy syndrome	0.00516	0.0258	CrCrCtD
Methylphenobarbital—GABRA6—Amobarbital—epilepsy syndrome	0.00507	0.0222	CbGbCtD
Methylphenobarbital—GABRA4—Amobarbital—epilepsy syndrome	0.00495	0.0216	CbGbCtD
Methylphenobarbital—Phenytoin—Carbamazepine—epilepsy syndrome	0.00484	0.0242	CrCrCtD
Methylphenobarbital—GRIK2—Topiramate—epilepsy syndrome	0.00436	0.019	CbGbCtD
Methylphenobarbital—GABRA3—Clonazepam—epilepsy syndrome	0.00422	0.0185	CbGbCtD
Methylphenobarbital—GABRA6—Primidone—epilepsy syndrome	0.00422	0.0184	CbGbCtD
Methylphenobarbital—GRIA2—Topiramate—epilepsy syndrome	0.00414	0.0181	CbGbCtD
Methylphenobarbital—GABRA4—Primidone—epilepsy syndrome	0.00411	0.018	CbGbCtD
Methylphenobarbital—GABRA5—Amobarbital—epilepsy syndrome	0.0039	0.0171	CbGbCtD
Methylphenobarbital—GABRA3—Amobarbital—epilepsy syndrome	0.00376	0.0164	CbGbCtD
Methylphenobarbital—GABRA2—Amobarbital—epilepsy syndrome	0.00364	0.0159	CbGbCtD
Methylphenobarbital—GABRA6—Midazolam—epilepsy syndrome	0.00356	0.0156	CbGbCtD
Methylphenobarbital—GABRA4—Midazolam—epilepsy syndrome	0.00347	0.0152	CbGbCtD
Methylphenobarbital—GABRA5—Primidone—epilepsy syndrome	0.00325	0.0142	CbGbCtD
Methylphenobarbital—GABRA1—Clonazepam—epilepsy syndrome	0.00323	0.0141	CbGbCtD
Methylphenobarbital—GABRA3—Primidone—epilepsy syndrome	0.00313	0.0137	CbGbCtD
Methylphenobarbital—GABRA1—Clobazam—epilepsy syndrome	0.00309	0.0135	CbGbCtD
Methylphenobarbital—GABRA2—Primidone—epilepsy syndrome	0.00303	0.0132	CbGbCtD
Methylphenobarbital—GABRA1—Amobarbital—epilepsy syndrome	0.00288	0.0126	CbGbCtD
Methylphenobarbital—GABRA5—Midazolam—epilepsy syndrome	0.00274	0.012	CbGbCtD
Methylphenobarbital—GABRA2—Propofol—epilepsy syndrome	0.00271	0.0118	CbGbCtD
Methylphenobarbital—GABRA3—Midazolam—epilepsy syndrome	0.00265	0.0116	CbGbCtD
Methylphenobarbital—GABRA5—Diazepam—epilepsy syndrome	0.00264	0.0115	CbGbCtD
Methylphenobarbital—GABRA2—Midazolam—epilepsy syndrome	0.00255	0.0112	CbGbCtD
Methylphenobarbital—GABRA3—Diazepam—epilepsy syndrome	0.00254	0.0111	CbGbCtD
Methylphenobarbital—GABRA2—Diazepam—epilepsy syndrome	0.00246	0.0107	CbGbCtD
Methylphenobarbital—GABRA1—Primidone—epilepsy syndrome	0.00239	0.0105	CbGbCtD
Methylphenobarbital—CYP2B6—Fosphenytoin—epilepsy syndrome	0.00216	0.00944	CbGbCtD
Methylphenobarbital—GABRA1—Propofol—epilepsy syndrome	0.00214	0.00937	CbGbCtD
Methylphenobarbital—GABRA1—Phenobarbital—epilepsy syndrome	0.00205	0.00895	CbGbCtD
Methylphenobarbital—GABRA1—Midazolam—epilepsy syndrome	0.00202	0.00883	CbGbCtD
Methylphenobarbital—GABRA1—Diazepam—epilepsy syndrome	0.00194	0.00849	CbGbCtD
Methylphenobarbital—CYP2B6—Clobazam—epilepsy syndrome	0.00187	0.00818	CbGbCtD
Methylphenobarbital—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.00157	0.00686	CbGbCtD
Methylphenobarbital—CYP2B6—Carbamazepine—epilepsy syndrome	0.00155	0.00678	CbGbCtD
Methylphenobarbital—CYP2C19—Felbamate—epilepsy syndrome	0.00146	0.00638	CbGbCtD
Methylphenobarbital—CYP2C19—Trimethadione—epilepsy syndrome	0.00146	0.00638	CbGbCtD
Methylphenobarbital—CYP2B6—Primidone—epilepsy syndrome	0.00145	0.00633	CbGbCtD
Methylphenobarbital—CYP2B6—Phenytoin—epilepsy syndrome	0.00139	0.00608	CbGbCtD
Methylphenobarbital—GABRA1—Topiramate—epilepsy syndrome	0.00138	0.00604	CbGbCtD
Methylphenobarbital—CYP2C19—Fosphenytoin—epilepsy syndrome	0.00137	0.006	CbGbCtD
Methylphenobarbital—GRIK2—cerebellar cortex—epilepsy syndrome	0.00137	0.0729	CbGeAlD
Methylphenobarbital—CYP2B6—Propofol—epilepsy syndrome	0.0013	0.00567	CbGbCtD
Methylphenobarbital—CYP2B6—Phenobarbital—epilepsy syndrome	0.00124	0.00542	CbGbCtD
Methylphenobarbital—CYP2B6—Midazolam—epilepsy syndrome	0.00122	0.00534	CbGbCtD
Methylphenobarbital—CYP2C19—Clobazam—epilepsy syndrome	0.00119	0.0052	CbGbCtD
Methylphenobarbital—CYP2B6—Diazepam—epilepsy syndrome	0.00118	0.00514	CbGbCtD
Methylphenobarbital—CYP2C19—Carbamazepine—epilepsy syndrome	0.000986	0.00431	CbGbCtD
Methylphenobarbital—CYP2B6—Valproic Acid—epilepsy syndrome	0.000927	0.00405	CbGbCtD
Methylphenobarbital—CYP2C19—Primidone—epilepsy syndrome	0.00092	0.00402	CbGbCtD
Methylphenobarbital—CYP2C19—Phenytoin—epilepsy syndrome	0.000884	0.00386	CbGbCtD
Methylphenobarbital—CYP2C19—Propofol—epilepsy syndrome	0.000825	0.0036	CbGbCtD
Methylphenobarbital—GRIK2—telencephalic ventricle—epilepsy syndrome	0.000795	0.0424	CbGeAlD
Methylphenobarbital—CYP2C19—Phenobarbital—epilepsy syndrome	0.000788	0.00344	CbGbCtD
Methylphenobarbital—CYP2C19—Diazepam—epilepsy syndrome	0.000747	0.00326	CbGbCtD
Methylphenobarbital—CYP2C19—Zonisamide—epilepsy syndrome	0.000729	0.00319	CbGbCtD
Methylphenobarbital—CHRNA4—autonomic nervous system—epilepsy syndrome	0.000716	0.0382	CbGeAlD
Methylphenobarbital—CHRNA4—telencephalic ventricle—epilepsy syndrome	0.000639	0.0341	CbGeAlD
Methylphenobarbital—CYP2C19—Valproic Acid—epilepsy syndrome	0.000589	0.00257	CbGbCtD
Methylphenobarbital—GRIA2—ganglion—epilepsy syndrome	0.000548	0.0292	CbGeAlD
Methylphenobarbital—CYP2C19—Topiramate—epilepsy syndrome	0.000531	0.00232	CbGbCtD
Methylphenobarbital—GRIK2—ganglion—epilepsy syndrome	0.000495	0.0264	CbGeAlD
Methylphenobarbital—GRIA2—hindbrain—epilepsy syndrome	0.000415	0.0222	CbGeAlD
Methylphenobarbital—CHRNA7—ganglion—epilepsy syndrome	0.000403	0.0215	CbGeAlD
Methylphenobarbital—GABRA6—hindbrain—epilepsy syndrome	0.000401	0.0214	CbGeAlD
Methylphenobarbital—CHRNA4—ganglion—epilepsy syndrome	0.000398	0.0212	CbGeAlD
Methylphenobarbital—GRIK2—hindbrain—epilepsy syndrome	0.000375	0.02	CbGeAlD
Methylphenobarbital—GABRA2—ganglion—epilepsy syndrome	0.000356	0.019	CbGeAlD
Methylphenobarbital—CHRNA4—hindbrain—epilepsy syndrome	0.000302	0.0161	CbGeAlD
Methylphenobarbital—GABRA2—hindbrain—epilepsy syndrome	0.00027	0.0144	CbGeAlD
Methylphenobarbital—GABRA1—hindbrain—epilepsy syndrome	0.000261	0.0139	CbGeAlD
Methylphenobarbital—GRIA2—brainstem—epilepsy syndrome	0.000238	0.0127	CbGeAlD
Methylphenobarbital—GABRA6—brainstem—epilepsy syndrome	0.00023	0.0123	CbGeAlD
Methylphenobarbital—GRIA2—forebrain—epilepsy syndrome	0.00023	0.0123	CbGeAlD
Methylphenobarbital—GABRA5—forebrain—epilepsy syndrome	0.000215	0.0115	CbGeAlD
Methylphenobarbital—GRIK2—brainstem—epilepsy syndrome	0.000215	0.0115	CbGeAlD
Methylphenobarbital—GRIA2—telencephalon—epilepsy syndrome	0.000211	0.0113	CbGeAlD
Methylphenobarbital—CHRFAM7A—forebrain—epilepsy syndrome	0.000209	0.0112	CbGeAlD
Methylphenobarbital—GRIK2—forebrain—epilepsy syndrome	0.000208	0.0111	CbGeAlD
Methylphenobarbital—GABRA6—telencephalon—epilepsy syndrome	0.000204	0.0109	CbGeAlD
Methylphenobarbital—GABRA5—telencephalon—epilepsy syndrome	0.000198	0.0106	CbGeAlD
Methylphenobarbital—GABRA4—forebrain—epilepsy syndrome	0.000195	0.0104	CbGeAlD
Methylphenobarbital—CHRFAM7A—telencephalon—epilepsy syndrome	0.000192	0.0103	CbGeAlD
Methylphenobarbital—GRIK2—telencephalon—epilepsy syndrome	0.000191	0.0102	CbGeAlD
Methylphenobarbital—GABRA4—telencephalon—epilepsy syndrome	0.00018	0.00958	CbGeAlD
Methylphenobarbital—CHRNA4—brainstem—epilepsy syndrome	0.000173	0.00922	CbGeAlD
Methylphenobarbital—CHRNA7—forebrain—epilepsy syndrome	0.000169	0.00902	CbGeAlD
Methylphenobarbital—CHRNA4—forebrain—epilepsy syndrome	0.000167	0.0089	CbGeAlD
Methylphenobarbital—CHRNA7—telencephalon—epilepsy syndrome	0.000155	0.00829	CbGeAlD
Methylphenobarbital—GABRA2—brainstem—epilepsy syndrome	0.000155	0.00825	CbGeAlD
Methylphenobarbital—CHRNA4—telencephalon—epilepsy syndrome	0.000153	0.00818	CbGeAlD
Methylphenobarbital—GRIA2—midbrain—epilepsy syndrome	0.000152	0.00809	CbGeAlD
Methylphenobarbital—GRIK2—medulla oblongata—epilepsy syndrome	0.00015	0.008	CbGeAlD
Methylphenobarbital—GABRA1—brainstem—epilepsy syndrome	0.000149	0.00797	CbGeAlD
Methylphenobarbital—GABRA2—forebrain—epilepsy syndrome	0.000149	0.00796	CbGeAlD
Methylphenobarbital—GRIA2—spinal cord—epilepsy syndrome	0.000148	0.0079	CbGeAlD
Methylphenobarbital—GABRA1—forebrain—epilepsy syndrome	0.000144	0.0077	CbGeAlD
Methylphenobarbital—GABRA2—telencephalon—epilepsy syndrome	0.000137	0.00732	CbGeAlD
Methylphenobarbital—GRIK2—midbrain—epilepsy syndrome	0.000137	0.00731	CbGeAlD
Methylphenobarbital—GRIK2—spinal cord—epilepsy syndrome	0.000134	0.00713	CbGeAlD
Methylphenobarbital—GABRA1—telencephalon—epilepsy syndrome	0.000133	0.00708	CbGeAlD
Methylphenobarbital—GRIA2—head—epilepsy syndrome	0.000132	0.00702	CbGeAlD
Methylphenobarbital—GABRA6—head—epilepsy syndrome	0.000127	0.00678	CbGeAlD
Methylphenobarbital—GRIA2—nervous system—epilepsy syndrome	0.000125	0.00665	CbGeAlD
Methylphenobarbital—GABRA5—head—epilepsy syndrome	0.000123	0.00658	CbGeAlD
Methylphenobarbital—GABRA6—nervous system—epilepsy syndrome	0.00012	0.00643	CbGeAlD
Methylphenobarbital—GRIA2—central nervous system—epilepsy syndrome	0.00012	0.0064	CbGeAlD
Methylphenobarbital—CHRFAM7A—head—epilepsy syndrome	0.00012	0.00639	CbGeAlD
Methylphenobarbital—GRIK2—head—epilepsy syndrome	0.000119	0.00634	CbGeAlD
Methylphenobarbital—GRIA2—cerebellum—epilepsy syndrome	0.000117	0.00626	CbGeAlD
Methylphenobarbital—GABRA5—nervous system—epilepsy syndrome	0.000117	0.00624	CbGeAlD
Methylphenobarbital—GABRA6—central nervous system—epilepsy syndrome	0.000116	0.00619	CbGeAlD
Methylphenobarbital—GABRA3—head—epilepsy syndrome	0.000115	0.00612	CbGeAlD
Methylphenobarbital—CHRFAM7A—nervous system—epilepsy syndrome	0.000114	0.00606	CbGeAlD
Methylphenobarbital—GABRA6—cerebellum—epilepsy syndrome	0.000113	0.00605	CbGeAlD
Methylphenobarbital—GRIK2—nervous system—epilepsy syndrome	0.000113	0.00601	CbGeAlD
Methylphenobarbital—GABRA5—central nervous system—epilepsy syndrome	0.000113	0.006	CbGeAlD
Methylphenobarbital—GABRA4—head—epilepsy syndrome	0.000112	0.00597	CbGeAlD
Methylphenobarbital—CHRNA4—midbrain—epilepsy syndrome	0.00011	0.00588	CbGeAlD
Methylphenobarbital—CHRFAM7A—central nervous system—epilepsy syndrome	0.000109	0.00584	CbGeAlD
Methylphenobarbital—GABRA3—nervous system—epilepsy syndrome	0.000109	0.0058	CbGeAlD
Methylphenobarbital—GRIK2—central nervous system—epilepsy syndrome	0.000108	0.00579	CbGeAlD
Methylphenobarbital—CHRNA4—spinal cord—epilepsy syndrome	0.000107	0.00573	CbGeAlD
Methylphenobarbital—GABRA4—nervous system—epilepsy syndrome	0.000106	0.00566	CbGeAlD
Methylphenobarbital—GRIK2—cerebellum—epilepsy syndrome	0.000106	0.00566	CbGeAlD
Methylphenobarbital—GABRA3—central nervous system—epilepsy syndrome	0.000105	0.00559	CbGeAlD
Methylphenobarbital—GABRA1—medulla oblongata—epilepsy syndrome	0.000104	0.00556	CbGeAlD
Methylphenobarbital—GABRA4—central nervous system—epilepsy syndrome	0.000102	0.00545	CbGeAlD
Methylphenobarbital—GABRA4—cerebellum—epilepsy syndrome	9.98e-05	0.00532	CbGeAlD
Methylphenobarbital—CHRNA7—head—epilepsy syndrome	9.68e-05	0.00516	CbGeAlD
Methylphenobarbital—CHRNA4—head—epilepsy syndrome	9.55e-05	0.00509	CbGeAlD
Methylphenobarbital—GRIA2—brain—epilepsy syndrome	9.53e-05	0.00508	CbGeAlD
Methylphenobarbital—GABRA1—midbrain—epilepsy syndrome	9.53e-05	0.00508	CbGeAlD
Methylphenobarbital—GABRA1—spinal cord—epilepsy syndrome	9.3e-05	0.00496	CbGeAlD
Methylphenobarbital—GABRA6—brain—epilepsy syndrome	9.21e-05	0.00491	CbGeAlD
Methylphenobarbital—CHRNA7—nervous system—epilepsy syndrome	9.18e-05	0.0049	CbGeAlD
Methylphenobarbital—CHRNA4—nervous system—epilepsy syndrome	9.05e-05	0.00483	CbGeAlD
Methylphenobarbital—GABRA5—brain—epilepsy syndrome	8.93e-05	0.00477	CbGeAlD
Methylphenobarbital—CHRNA7—central nervous system—epilepsy syndrome	8.84e-05	0.00471	CbGeAlD
Methylphenobarbital—CHRNA4—central nervous system—epilepsy syndrome	8.72e-05	0.00465	CbGeAlD
Methylphenobarbital—CHRFAM7A—brain—epilepsy syndrome	8.69e-05	0.00463	CbGeAlD
Methylphenobarbital—GRIK2—brain—epilepsy syndrome	8.61e-05	0.00459	CbGeAlD
Methylphenobarbital—GABRA2—head—epilepsy syndrome	8.55e-05	0.00456	CbGeAlD
Methylphenobarbital—CHRNA4—cerebellum—epilepsy syndrome	8.52e-05	0.00454	CbGeAlD
Methylphenobarbital—GABRA3—brain—epilepsy syndrome	8.32e-05	0.00444	CbGeAlD
Methylphenobarbital—GABRA1—head—epilepsy syndrome	8.26e-05	0.00441	CbGeAlD
Methylphenobarbital—GABRA4—brain—epilepsy syndrome	8.11e-05	0.00432	CbGeAlD
Methylphenobarbital—GABRA2—nervous system—epilepsy syndrome	8.1e-05	0.00432	CbGeAlD
Methylphenobarbital—GABRA1—nervous system—epilepsy syndrome	7.83e-05	0.00418	CbGeAlD
Methylphenobarbital—GABRA2—central nervous system—epilepsy syndrome	7.8e-05	0.00416	CbGeAlD
Methylphenobarbital—GABRA2—cerebellum—epilepsy syndrome	7.63e-05	0.00407	CbGeAlD
Methylphenobarbital—GABRA1—central nervous system—epilepsy syndrome	7.54e-05	0.00402	CbGeAlD
Methylphenobarbital—GABRA1—cerebellum—epilepsy syndrome	7.37e-05	0.00393	CbGeAlD
Methylphenobarbital—Methsuximide—CACNA1G—epilepsy syndrome	7.12e-05	0.0363	CrCbGaD
Methylphenobarbital—CHRNA7—brain—epilepsy syndrome	7.01e-05	0.00374	CbGeAlD
Methylphenobarbital—CHRNA4—brain—epilepsy syndrome	6.92e-05	0.00369	CbGeAlD
Methylphenobarbital—Phensuximide—CACNA1G—epilepsy syndrome	6.89e-05	0.0352	CrCbGaD
Methylphenobarbital—Hexobarbital—GRIA2—epilepsy syndrome	6.77e-05	0.0346	CrCbGaD
Methylphenobarbital—Ethotoin—SCN8A—epilepsy syndrome	6.74e-05	0.0344	CrCbGaD
Methylphenobarbital—Methohexital—GABRG2—epilepsy syndrome	6.51e-05	0.0332	CrCbGaD
Methylphenobarbital—Methsuximide—CACNA1H—epilepsy syndrome	6.41e-05	0.0327	CrCbGaD
Methylphenobarbital—Phensuximide—CACNA1H—epilepsy syndrome	6.21e-05	0.0317	CrCbGaD
Methylphenobarbital—GABRA2—brain—epilepsy syndrome	6.19e-05	0.0033	CbGeAlD
Methylphenobarbital—GABRA1—brain—epilepsy syndrome	5.99e-05	0.00319	CbGeAlD
Methylphenobarbital—Ethotoin—SCN9A—epilepsy syndrome	5.45e-05	0.0278	CrCbGaD
Methylphenobarbital—Methohexital—GABRB3—epilepsy syndrome	5.24e-05	0.0267	CrCbGaD
Methylphenobarbital—Ethotoin—SCN3A—epilepsy syndrome	5.21e-05	0.0266	CrCbGaD
Methylphenobarbital—Glutethimide—GABRG2—epilepsy syndrome	5.06e-05	0.0258	CrCbGaD
Methylphenobarbital—Ethotoin—SCN4A—epilepsy syndrome	5.01e-05	0.0256	CrCbGaD
Methylphenobarbital—CYP2B6—head—epilepsy syndrome	4.87e-05	0.0026	CbGeAlD
Methylphenobarbital—Hexobarbital—CHRNA7—epilepsy syndrome	4.79e-05	0.0245	CrCbGaD
Methylphenobarbital—CYP2B6—nervous system—epilepsy syndrome	4.62e-05	0.00246	CbGeAlD
Methylphenobarbital—Hexobarbital—GABRA5—epilepsy syndrome	4.56e-05	0.0233	CrCbGaD
Methylphenobarbital—Methohexital—GABRA1—epilepsy syndrome	4.5e-05	0.023	CrCbGaD
Methylphenobarbital—Hexobarbital—GRIK2—epilepsy syndrome	4.48e-05	0.0229	CrCbGaD
Methylphenobarbital—CYP2B6—central nervous system—epilepsy syndrome	4.45e-05	0.00237	CbGeAlD
Methylphenobarbital—Glutethimide—CYP11A1—epilepsy syndrome	4.3e-05	0.022	CrCbGaD
Methylphenobarbital—Phenytoin—SCN8A—epilepsy syndrome	4.11e-05	0.021	CrCbGaD
Methylphenobarbital—Glutethimide—GABRB3—epilepsy syndrome	4.07e-05	0.0208	CrCbGaD
Methylphenobarbital—Primidone—GRIA2—epilepsy syndrome	3.92e-05	0.02	CrCbGaD
Methylphenobarbital—Hexobarbital—GABRA1—epilepsy syndrome	3.91e-05	0.02	CrCbGaD
Methylphenobarbital—Hexobarbital—CHRNA4—epilepsy syndrome	3.83e-05	0.0195	CrCbGaD
Methylphenobarbital—Ethotoin—SCN1A—epilepsy syndrome	3.66e-05	0.0187	CrCbGaD
Methylphenobarbital—CYP2B6—brain—epilepsy syndrome	3.53e-05	0.00188	CbGeAlD
Methylphenobarbital—Glutethimide—GABRA1—epilepsy syndrome	3.5e-05	0.0179	CrCbGaD
Methylphenobarbital—Pethidine—GRIN2A—epilepsy syndrome	3.35e-05	0.0171	CrCbGaD
Methylphenobarbital—Phenytoin—SCN9A—epilepsy syndrome	3.33e-05	0.017	CrCbGaD
Methylphenobarbital—Primidone—GABRG2—epilepsy syndrome	3.28e-05	0.0168	CrCbGaD
Methylphenobarbital—Ethotoin—SCN2A—epilepsy syndrome	3.23e-05	0.0165	CrCbGaD
Methylphenobarbital—Phenytoin—SCN3A—epilepsy syndrome	3.18e-05	0.0162	CrCbGaD
Methylphenobarbital—Phenytoin—SCN4A—epilepsy syndrome	3.06e-05	0.0156	CrCbGaD
Methylphenobarbital—Pethidine—GRIN2B—epilepsy syndrome	2.84e-05	0.0145	CrCbGaD
Methylphenobarbital—Primidone—CHRNA7—epilepsy syndrome	2.78e-05	0.0142	CrCbGaD
Methylphenobarbital—Primidone—GABRA5—epilepsy syndrome	2.64e-05	0.0135	CrCbGaD
Methylphenobarbital—Primidone—GRIK2—epilepsy syndrome	2.59e-05	0.0132	CrCbGaD
Methylphenobarbital—Phenobarbital—GRIA2—epilepsy syndrome	2.48e-05	0.0126	CrCbGaD
Methylphenobarbital—Primidone—GABRB2—epilepsy syndrome	2.31e-05	0.0118	CrCbGaD
Methylphenobarbital—Primidone—GABRA1—epilepsy syndrome	2.27e-05	0.0116	CrCbGaD
Methylphenobarbital—Phenytoin—SCN1A—epilepsy syndrome	2.23e-05	0.0114	CrCbGaD
Methylphenobarbital—Primidone—CHRNA4—epilepsy syndrome	2.22e-05	0.0113	CrCbGaD
Methylphenobarbital—Phenytoin—SCN2A—epilepsy syndrome	1.97e-05	0.0101	CrCbGaD
Methylphenobarbital—Hexobarbital—CYP2C19—epilepsy syndrome	1.84e-05	0.00939	CrCbGaD
Methylphenobarbital—Pethidine—OPRM1—epilepsy syndrome	1.82e-05	0.00931	CrCbGaD
Methylphenobarbital—Phenobarbital—CHRNA7—epilepsy syndrome	1.75e-05	0.00894	CrCbGaD
Methylphenobarbital—Phenobarbital—GRIK2—epilepsy syndrome	1.64e-05	0.00836	CrCbGaD
Methylphenobarbital—Methsuximide—CYP2C19—epilepsy syndrome	1.6e-05	0.00818	CrCbGaD
Methylphenobarbital—Fosphenytoin—CYP2C19—epilepsy syndrome	1.59e-05	0.00811	CrCbGaD
Methylphenobarbital—Phensuximide—CYP2C19—epilepsy syndrome	1.55e-05	0.00792	CrCbGaD
Methylphenobarbital—Phenobarbital—GABRA1—epilepsy syndrome	1.43e-05	0.00731	CrCbGaD
Methylphenobarbital—Phenobarbital—CHRNA4—epilepsy syndrome	1.4e-05	0.00715	CrCbGaD
Methylphenobarbital—Antipyrine—CYP2C19—epilepsy syndrome	1.38e-05	0.00703	CrCbGaD
Methylphenobarbital—Glutethimide—CYP2D6—epilepsy syndrome	1.22e-05	0.00622	CrCbGaD
Methylphenobarbital—Ethotoin—CYP2C19—epilepsy syndrome	1.15e-05	0.00587	CrCbGaD
Methylphenobarbital—Primidone—CYP2C19—epilepsy syndrome	1.07e-05	0.00544	CrCbGaD
Methylphenobarbital—Antipyrine—CYP2D6—epilepsy syndrome	1.02e-05	0.00521	CrCbGaD
Methylphenobarbital—Phenytoin—ABCC2—epilepsy syndrome	1.01e-05	0.00515	CrCbGaD
Methylphenobarbital—Pethidine—SLC6A4—epilepsy syndrome	1e-05	0.00513	CrCbGaD
Methylphenobarbital—Phenobarbital—ABCC2—epilepsy syndrome	9.68e-06	0.00494	CrCbGaD
Methylphenobarbital—Pethidine—CYP2C19—epilepsy syndrome	9.53e-06	0.00486	CrCbGaD
Methylphenobarbital—Fosphenytoin—ALB—epilepsy syndrome	8.81e-06	0.0045	CrCbGaD
Methylphenobarbital—Antipyrine—PTGS2—epilepsy syndrome	8.58e-06	0.00438	CrCbGaD
Methylphenobarbital—Pethidine—CYP2D6—epilepsy syndrome	7.06e-06	0.00361	CrCbGaD
Methylphenobarbital—Phenytoin—CYP2C19—epilepsy syndrome	7.02e-06	0.00358	CrCbGaD
Methylphenobarbital—Phenobarbital—CYP2C19—epilepsy syndrome	6.73e-06	0.00343	CrCbGaD
Methylphenobarbital—Pethidine—ALB—epilepsy syndrome	5.28e-06	0.0027	CrCbGaD
Methylphenobarbital—GABRA6—Transmission across Chemical Synapses—PRKCB—epilepsy syndrome	4.46e-06	0.000106	CbGpPWpGaD
Methylphenobarbital—CHRNA7—SIDS Susceptibility Pathways—VEGFA—epilepsy syndrome	4.45e-06	0.000106	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	4.44e-06	0.000106	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmission across Chemical Synapses—PRKCB—epilepsy syndrome	4.4e-06	0.000105	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	4.38e-06	0.000104	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	4.38e-06	0.000104	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	4.38e-06	0.000104	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	4.36e-06	0.000104	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	4.35e-06	0.000104	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neuronal System—BCHE—epilepsy syndrome	4.35e-06	0.000103	CbGpPWpGaD
Methylphenobarbital—CHRNA4—SIDS Susceptibility Pathways—IL1B—epilepsy syndrome	4.29e-06	0.000102	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—epilepsy syndrome	4.28e-06	0.000102	CbGpPWpGaD
Methylphenobarbital—CHRNA4—SIDS Susceptibility Pathways—CASP3—epilepsy syndrome	4.28e-06	0.000102	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	4.27e-06	0.000102	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	4.27e-06	0.000102	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neuronal System—DLG4—epilepsy syndrome	4.24e-06	0.000101	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	4.23e-06	0.000101	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	4.22e-06	0.0001	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	4.2e-06	0.0001	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	4.2e-06	0.0001	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	4.2e-06	9.99e-05	CbGpPWpGaD
Methylphenobarbital—CHRNA4—SIDS Susceptibility Pathways—JUN—epilepsy syndrome	4.15e-06	9.88e-05	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neuronal System—GRIN2B—epilepsy syndrome	4.15e-06	9.86e-05	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	4.13e-06	9.82e-05	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	4.13e-06	9.82e-05	CbGpPWpGaD
Methylphenobarbital—GRIA2—Neuronal System—PRKCB—epilepsy syndrome	4.11e-06	9.77e-05	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neuronal System—PLCB1—epilepsy syndrome	4.1e-06	9.76e-05	CbGpPWpGaD
Methylphenobarbital—GRIA2—BDNF signaling pathway—SRC—epilepsy syndrome	4.1e-06	9.74e-05	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	4.07e-06	9.68e-05	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	4.06e-06	9.65e-05	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	4.06e-06	9.65e-05	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	4.03e-06	9.59e-05	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Neuronal System—PRKCB—epilepsy syndrome	3.98e-06	9.47e-05	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	3.96e-06	9.42e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	3.95e-06	9.39e-05	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmission across Chemical Synapses—PRKCB—epilepsy syndrome	3.91e-06	9.3e-05	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	3.91e-06	9.29e-05	CbGpPWpGaD
Methylphenobarbital—Phenytoin—ALB—epilepsy syndrome	3.89e-06	0.00199	CrCbGaD
Methylphenobarbital—GABRA2—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	3.89e-06	9.25e-05	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	3.88e-06	9.23e-05	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	3.86e-06	9.18e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Biological oxidations—CYP11A1—epilepsy syndrome	3.84e-06	9.14e-05	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmission across Chemical Synapses—PRKCB—epilepsy syndrome	3.84e-06	9.14e-05	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	3.83e-06	9.1e-05	CbGpPWpGaD
Methylphenobarbital—CHRNA7—SIDS Susceptibility Pathways—TNF—epilepsy syndrome	3.82e-06	9.08e-05	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	3.81e-06	9.06e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metapathway biotransformation—CYP11A1—epilepsy syndrome	3.79e-06	9.02e-05	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmission across Chemical Synapses—PRKCB—epilepsy syndrome	3.77e-06	8.98e-05	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	3.76e-06	8.94e-05	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	3.75e-06	8.91e-05	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	3.72e-06	8.85e-05	CbGpPWpGaD
Methylphenobarbital—Phenytoin—ABCB1—epilepsy syndrome	3.71e-06	0.0019	CrCbGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	3.68e-06	8.75e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Arachidonic acid metabolism—PTGS2—epilepsy syndrome	3.64e-06	8.66e-05	CbGpPWpGaD
Methylphenobarbital—CHRNA4—SIDS Susceptibility Pathways—VEGFA—epilepsy syndrome	3.63e-06	8.63e-05	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	3.62e-06	8.6e-05	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	3.58e-06	8.52e-05	CbGpPWpGaD
Methylphenobarbital—Phenobarbital—ABCB1—epilepsy syndrome	3.56e-06	0.00182	CrCbGaD
Methylphenobarbital—CYP2B6—Metabolism—CA13—epilepsy syndrome	3.5e-06	8.33e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Biological oxidations—CYP2D6—epilepsy syndrome	3.47e-06	8.25e-05	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	3.46e-06	8.23e-05	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	3.46e-06	8.23e-05	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	3.43e-06	8.15e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metapathway biotransformation—CYP2D6—epilepsy syndrome	3.42e-06	8.14e-05	CbGpPWpGaD
Methylphenobarbital—GABRA6—Neuronal System—PRKCB—epilepsy syndrome	3.42e-06	8.12e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	3.41e-06	8.12e-05	CbGpPWpGaD
Methylphenobarbital—GABRA4—Neuronal System—PRKCB—epilepsy syndrome	3.37e-06	8.02e-05	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	3.37e-06	8.01e-05	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	3.34e-06	7.94e-05	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	3.32e-06	7.89e-05	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	3.31e-06	7.87e-05	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	3.28e-06	7.8e-05	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	3.24e-06	7.7e-05	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	3.22e-06	7.67e-05	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmission across Chemical Synapses—PRKCB—epilepsy syndrome	3.22e-06	7.66e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	3.2e-06	7.61e-05	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	3.2e-06	7.6e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	3.12e-06	7.42e-05	CbGpPWpGaD
Methylphenobarbital—CHRNA4—SIDS Susceptibility Pathways—TNF—epilepsy syndrome	3.11e-06	7.4e-05	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	3.09e-06	7.35e-05	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	3.08e-06	7.33e-05	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	3.05e-06	7.25e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	3e-06	7.15e-05	CbGpPWpGaD
Methylphenobarbital—GABRA5—Neuronal System—PRKCB—epilepsy syndrome	3e-06	7.13e-05	CbGpPWpGaD
Methylphenobarbital—GABRA3—Neuronal System—PRKCB—epilepsy syndrome	2.94e-06	7e-05	CbGpPWpGaD
Methylphenobarbital—GABRA2—Neuronal System—PRKCB—epilepsy syndrome	2.89e-06	6.88e-05	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	2.84e-06	6.76e-05	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	2.82e-06	6.71e-05	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	2.79e-06	6.63e-05	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	2.75e-06	6.54e-05	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	2.74e-06	6.52e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	2.73e-06	6.49e-05	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	2.71e-06	6.44e-05	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	2.66e-06	6.33e-05	CbGpPWpGaD
Methylphenobarbital—GABRA1—SIDS Susceptibility Pathways—IL1B—epilepsy syndrome	2.65e-06	6.31e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—L2HGDH—epilepsy syndrome	2.65e-06	6.31e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—FAR1—epilepsy syndrome	2.65e-06	6.31e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—CERS1—epilepsy syndrome	2.65e-06	6.31e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—PDXK—epilepsy syndrome	2.65e-06	6.31e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—GLUD1—epilepsy syndrome	2.65e-06	6.31e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—ADK—epilepsy syndrome	2.65e-06	6.31e-05	CbGpPWpGaD
Methylphenobarbital—GABRA1—SIDS Susceptibility Pathways—CASP3—epilepsy syndrome	2.65e-06	6.3e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—CA13—epilepsy syndrome	2.65e-06	6.29e-05	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	2.61e-06	6.22e-05	CbGpPWpGaD
Methylphenobarbital—GABRA1—SIDS Susceptibility Pathways—JUN—epilepsy syndrome	2.57e-06	6.12e-05	CbGpPWpGaD
Methylphenobarbital—GRIA2—BDNF signaling pathway—AKT1—epilepsy syndrome	2.55e-06	6.06e-05	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	2.54e-06	6.04e-05	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmembrane transport of small molecules—AVP—epilepsy syndrome	2.52e-06	5.99e-05	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	2.51e-06	5.97e-05	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmembrane transport of small molecules—AVP—epilepsy syndrome	2.49e-06	5.91e-05	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neuronal System—PRKCB—epilepsy syndrome	2.47e-06	5.87e-05	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	2.44e-06	5.8e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—NHLRC1—epilepsy syndrome	2.43e-06	5.77e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—PNPO—epilepsy syndrome	2.43e-06	5.77e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—EPM2A—epilepsy syndrome	2.43e-06	5.77e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—GAMT—epilepsy syndrome	2.43e-06	5.77e-05	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	2.41e-06	5.73e-05	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	2.34e-06	5.56e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—QDPR—epilepsy syndrome	2.26e-06	5.37e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—CA4—epilepsy syndrome	2.26e-06	5.37e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Biological oxidations—POMC—epilepsy syndrome	2.25e-06	5.35e-05	CbGpPWpGaD
Methylphenobarbital—GABRA1—SIDS Susceptibility Pathways—VEGFA—epilepsy syndrome	2.25e-06	5.34e-05	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	2.23e-06	5.3e-05	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	2.23e-06	5.3e-05	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—AVP—epilepsy syndrome	2.21e-06	5.25e-05	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	2.19e-06	5.21e-05	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—AVP—epilepsy syndrome	2.17e-06	5.16e-05	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	2.15e-06	5.12e-05	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	2.14e-06	5.09e-05	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmembrane transport of small molecules—AVP—epilepsy syndrome	2.13e-06	5.07e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	2.13e-06	5.07e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—COX3—epilepsy syndrome	2.12e-06	5.05e-05	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	2.1e-06	5e-05	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	2.06e-06	4.91e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—PFKL—epilepsy syndrome	2.01e-06	4.78e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—SLC6A8—epilepsy syndrome	2.01e-06	4.78e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—CACNA2D2—epilepsy syndrome	2.01e-06	4.78e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—KCNB1—epilepsy syndrome	2.01e-06	4.78e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—SLCO1A2—epilepsy syndrome	2.01e-06	4.78e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—L2HGDH—epilepsy syndrome	2.01e-06	4.77e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—PDXK—epilepsy syndrome	2.01e-06	4.77e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—FAR1—epilepsy syndrome	2.01e-06	4.77e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—ADK—epilepsy syndrome	2.01e-06	4.77e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—GLUD1—epilepsy syndrome	2.01e-06	4.77e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—CERS1—epilepsy syndrome	2.01e-06	4.77e-05	CbGpPWpGaD
Methylphenobarbital—GABRA1—SIDS Susceptibility Pathways—TNF—epilepsy syndrome	1.93e-06	4.58e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—NEU1—epilepsy syndrome	1.84e-06	4.38e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—UPB1—epilepsy syndrome	1.84e-06	4.38e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—ATIC—epilepsy syndrome	1.84e-06	4.38e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—PNPO—epilepsy syndrome	1.83e-06	4.36e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—EPM2A—epilepsy syndrome	1.83e-06	4.36e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—GAMT—epilepsy syndrome	1.83e-06	4.36e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—NHLRC1—epilepsy syndrome	1.83e-06	4.36e-05	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.83e-06	4.36e-05	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.82e-06	4.32e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—HSD17B4—epilepsy syndrome	1.77e-06	4.21e-05	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	1.76e-06	4.19e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—GBE1—epilepsy syndrome	1.71e-06	4.07e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—PPP1R3C—epilepsy syndrome	1.71e-06	4.07e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—CA4—epilepsy syndrome	1.71e-06	4.06e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—QDPR—epilepsy syndrome	1.71e-06	4.06e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Biological oxidations—POMC—epilepsy syndrome	1.7e-06	4.04e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—ASAH1—epilepsy syndrome	1.61e-06	3.82e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—COX3—epilepsy syndrome	1.6e-06	3.81e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—STXBP1—epilepsy syndrome	1.56e-06	3.72e-05	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.53e-06	3.63e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—ALAD—epilepsy syndrome	1.52e-06	3.63e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—NT5E—epilepsy syndrome	1.52e-06	3.63e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—CACNA2D2—epilepsy syndrome	1.52e-06	3.61e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—PFKL—epilepsy syndrome	1.52e-06	3.61e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—SLC6A8—epilepsy syndrome	1.52e-06	3.61e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—SLCO1A2—epilepsy syndrome	1.52e-06	3.61e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—KCNB1—epilepsy syndrome	1.52e-06	3.61e-05	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.51e-06	3.58e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	1.48e-06	3.51e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—ALDH7A1—epilepsy syndrome	1.45e-06	3.46e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—CACNA1A—epilepsy syndrome	1.45e-06	3.46e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—ST3GAL3—epilepsy syndrome	1.42e-06	3.38e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—ADSL—epilepsy syndrome	1.39e-06	3.32e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—ATIC—epilepsy syndrome	1.39e-06	3.31e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—UPB1—epilepsy syndrome	1.39e-06	3.31e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—NEU1—epilepsy syndrome	1.39e-06	3.31e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—GLUL—epilepsy syndrome	1.37e-06	3.25e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—CACNA1D—epilepsy syndrome	1.34e-06	3.19e-05	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.34e-06	3.18e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—HSD17B4—epilepsy syndrome	1.34e-06	3.18e-05	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.31e-06	3.13e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—PPP1R3C—epilepsy syndrome	1.29e-06	3.07e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—GBE1—epilepsy syndrome	1.29e-06	3.07e-05	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.29e-06	3.07e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.26e-06	3e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—TXNRD1—epilepsy syndrome	1.26e-06	2.99e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—AQP1—epilepsy syndrome	1.22e-06	2.9e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—ASAH1—epilepsy syndrome	1.21e-06	2.89e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—STXBP1—epilepsy syndrome	1.18e-06	2.81e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—ALAD—epilepsy syndrome	1.15e-06	2.74e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—NT5E—epilepsy syndrome	1.15e-06	2.74e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—CHRM3—epilepsy syndrome	1.1e-06	2.62e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—KCNJ11—epilepsy syndrome	1.1e-06	2.62e-05	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.1e-06	2.62e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—ALDH7A1—epilepsy syndrome	1.1e-06	2.61e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—CACNA1A—epilepsy syndrome	1.1e-06	2.61e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—ST3GAL3—epilepsy syndrome	1.08e-06	2.56e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—ADSL—epilepsy syndrome	1.05e-06	2.51e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—GLUL—epilepsy syndrome	1.03e-06	2.46e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—CACNA1D—epilepsy syndrome	1.01e-06	2.41e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—TXNRD1—epilepsy syndrome	9.48e-07	2.26e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—AQP1—epilepsy syndrome	9.21e-07	2.19e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—ABCG2—epilepsy syndrome	8.98e-07	2.14e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	8.84e-07	2.1e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—CYP2C19—epilepsy syndrome	8.75e-07	2.08e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—CYP11A1—epilepsy syndrome	8.7e-07	2.07e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—CHRM3—epilepsy syndrome	8.33e-07	1.98e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—KCNJ11—epilepsy syndrome	8.33e-07	1.98e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—CYP2D6—epilepsy syndrome	7.85e-07	1.87e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	7.75e-07	1.84e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	7.6e-07	1.81e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—ADRA2A—epilepsy syndrome	7.47e-07	1.78e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—BCHE—epilepsy syndrome	7.44e-07	1.77e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—SLC2A1—epilepsy syndrome	7.1e-07	1.69e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—PLCB1—epilepsy syndrome	7.02e-07	1.67e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—TH—epilepsy syndrome	7e-07	1.66e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	6.79e-07	1.61e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	6.57e-07	1.56e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	6.53e-07	1.55e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	5.95e-07	1.42e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	5.93e-07	1.41e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—HMOX1—epilepsy syndrome	5.84e-07	1.39e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—CAT—epilepsy syndrome	5.76e-07	1.37e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	5.65e-07	1.34e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—BCHE—epilepsy syndrome	5.62e-07	1.34e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—ABCB1—epilepsy syndrome	5.61e-07	1.33e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	5.37e-07	1.28e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	5.31e-07	1.26e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—TH—epilepsy syndrome	5.29e-07	1.26e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—GPX1—epilepsy syndrome	5.21e-07	1.24e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	5.21e-07	1.24e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—AGT—epilepsy syndrome	4.57e-07	1.09e-05	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—APOE—epilepsy syndrome	4.48e-07	1.07e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	4.41e-07	1.05e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—CAT—epilepsy syndrome	4.35e-07	1.04e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	4.24e-07	1.01e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—GPX1—epilepsy syndrome	3.94e-07	9.37e-06	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—POMC—epilepsy syndrome	3.85e-07	9.15e-06	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—ALB—epilepsy syndrome	3.51e-07	8.34e-06	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—AGT—epilepsy syndrome	3.45e-07	8.21e-06	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—APOE—epilepsy syndrome	3.38e-07	8.05e-06	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—PTGS2—epilepsy syndrome	3.07e-07	7.3e-06	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—POMC—epilepsy syndrome	2.91e-07	6.91e-06	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—ALB—epilepsy syndrome	2.65e-07	6.3e-06	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	2.32e-07	5.52e-06	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—AKT1—epilepsy syndrome	1.54e-07	3.67e-06	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—AKT1—epilepsy syndrome	1.17e-07	2.77e-06	CbGpPWpGaD
